Form 4 for RMD ResMed|
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-15 · accession 0001127602-23-005682 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-02-16 | 2023-02-15 | RMD | Douglas Robert Andrew | Pres, COO | S - Sale | $213.50 | -1,500 | 261.4K | -0.6% | -$320.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2023-02-15 | S | D | 1,500 | $213.50 | 261,445 | I Douglas Family Trust | — | — | (F2) Includes a transfer of shares between direct and indirect holdings on 2/8/2023. |